venBio Partners
Latest statistics and disclosures from venBio Partners's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ALXO, PHVS, HRMY, SLRN, ELEV, and represent 100.00% of venBio Partners's stock portfolio.
- Reduced shares in these 4 stocks: Rayzebio (-$321M), PHVS (-$15M), ELEV, IMPLQ.
- Sold out of its positions in IMPLQ, Rayzebio.
- venBio Partners was a net seller of stock by $-337M.
- venBio Partners has $282M in assets under management (AUM), dropping by -57.75%.
- Central Index Key (CIK): 0001776382
Tip: Access up to 7 years of quarterly data
Positions held by venBio Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelPortfolio Holdings for venBio Partners
venBio Partners holds 5 positions in its portfolio as reported in the March 2024 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Alx Oncology Hldgs (ALXO) | 38.4 | $108M | 9.7M | 11.15 |
|
|
Pharvaris N V (PHVS) | 35.2 | $99M | -12% | 4.3M | 23.11 |
|
Harmony Biosciences Hldgs In (HRMY) | 12.3 | $35M | 1.0M | 33.58 |
|
|
Acelyrin (SLRN) | 9.2 | $26M | 3.9M | 6.75 |
|
|
Elevation Oncology (ELEV) | 4.9 | $14M | -7% | 2.7M | 5.13 |
|
Past Filings by venBio Partners
SEC 13F filings are viewable for venBio Partners going back to 2019
- venBio Partners 2024 Q1 filed May 15, 2024
- venBio Partners 2023 Q4 filed Feb. 14, 2024
- venBio Partners 2023 Q3 filed Nov. 14, 2023
- venBio Partners 2023 Q2 filed Aug. 14, 2023
- venBio Partners 2023 Q1 filed May 15, 2023
- venBio Partners 2022 Q4 filed Feb. 14, 2023
- venBio Partners 2022 Q3 filed Nov. 14, 2022
- venBio Partners 2022 Q2 filed Aug. 15, 2022
- venBio Partners 2022 Q1 filed May 16, 2022
- venBio Partners 2021 Q4 filed Feb. 14, 2022
- venBio Partners 2021 Q3 filed Nov. 15, 2021
- venBio Partners 2021 Q2 filed Aug. 16, 2021
- venBio Partners 2021 Q1 filed May 17, 2021
- venBio Partners 2020 Q4 filed Feb. 16, 2021
- venBio Partners 2020 Q3 filed Nov. 16, 2020
- venBio Partners 2020 Q2 filed Aug. 14, 2020